Dwilow R, Fanella S. Invasive meningococcal disease in the 21st century—an update for the clinician. Curr Neurol Neurosci Rep. 2015;15:2.
Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367:397–403.
Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37:2768–82.
Olbrich KJ, Muller D, Schumacher S, et al. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7:421–38.
Article PubMed PubMed Central Google Scholar
Acevedo R, Bai X, Borrow R, et al. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18:15–30.
Article PubMed CAS Google Scholar
Soumahoro L, Abitbol V, Vicic N, Bekkat-Berkani R, Safadi MAP. Meningococcal disease outbreaks: a moving target and a case for routine preventative vaccination. Infect Dis Ther. 2021;10:1949–88.
Article PubMed PubMed Central Google Scholar
Harrison LH, Jolley KA, Shutt KA, et al. Antigenic shift and increased incidence of meningococcal disease. J Infect Dis. 2006;193:1266–74.
Article PubMed CAS Google Scholar
Swartley JS, Marfin AA, Edupuganti S, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA. 1997;94:271–6.
Article PubMed PubMed Central CAS Google Scholar
Tzeng YL, Stephens DS. A narrative review of the W, X, Y, E, and NG of meningococcal disease: emerging capsular groups, pathotypes, and global control. Microorganisms. 2021;9:519.
Article PubMed PubMed Central CAS Google Scholar
Miller E, Salisbury D, Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine. 2001;20:S58–67.
Knol MJ, Hahne SJM, Lucidarme J, et al. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017;2:e473–82.
World Health Organization. Defeating meningitis by 2030: a global road map. Jun 24, 2021. Available at: https://www.who.int/publications/i/item/9789240026407. Accessed 21 Dec 2022.
Parikh SR, Campbell H, Bettinger JA, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81:483–98.
Burman C, Serra L, Nuttens C, et al. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15:459–69.
Martinon-Torres F, Taha MK, Knuf M, et al. Evolving strategies for meningococcal vaccination in Europe: overview and key determinants for current and future considerations. Pathog Glob Health. 2022;116:85–98.
Article PubMed CAS Google Scholar
Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3:e360–70.
Article PubMed PubMed Central CAS Google Scholar
Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51:418–23.
Article PubMed PubMed Central Google Scholar
UNICEF. COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows. July 15, 2021. Available at: https://www.unicef.org/press-releases/covid-19-pandemic-leads-major-backsliding-childhood-vaccinations-new-who-unicef-data. Accessed 21 Dec 2022.
Alderson MR, Arkwright PD, Bai X, et al. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J Infect. 2022;84:289–96.
Article PubMed CAS Google Scholar
Clark SA, Campbell H, Mensah AA, et al. An increase in group B invasive meningococcal disease among adolescents and young adults in England following easing of COVID-19 containment measures. SSRN Electron J. 2022. https://doi.org/10.2139/ssrn.3998164. (Preprint posted online January 8, 2022).
Santé publique France. [Epidemiological situation of invasive meningococcal infections in France. Update as of December 31, 2022]. Available at: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/infections-invasives-a-meningocoque/documents/bulletin-national2/situation-epidemiologique-des-infections-invasives-a-meningocoque-en-france.-point-au-31-decembre-2022#:~:text=Avec%2084%20cas%20d'IIM,et%20mars%20selon%20la%20saison. Accessed 1 Mar 2023.
Han E, Tan MMJ, Turk E, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–34.
Article PubMed PubMed Central CAS Google Scholar
European Centre for Disease Prevention and Control. Meningococcal disease: recommended vaccinations. Available at: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=48&SelectedCountryIdByDisease=-1. Accessed 21 Dec 2022.
Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124–8.
Article PubMed PubMed Central Google Scholar
Aparecido Nunes A, De De Jesus Lopes Abreu A, Cintra O, et al. Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination. Vaccine. 2021;39:605–16.
Graña MG, Cavada G, Vasquez M, et al. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile. Hum Vaccin Immunother. 2021;17:5603–13.
Article PubMed PubMed Central Google Scholar
McMillan M, Wang B, Koehler AP, Sullivan TR, Marshall HS. Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents. Clin Infect Dis. 2021;73:e233–7.
Rubis A. Epidemiology of meningococcal disease in the United States. Presented at: Advisory Committee on Immunization Practices Meeting, February 23, 2023; Atlanta, GA, USA.
Ministère de la Santé et de la Prévention. Calendrier des vaccinations et recommandations vaccinales 2023. Available at: https://sante.gouv.fr/IMG/pdf/calendrier_vaccinal_maj-juin23.pdf. Accessed 14 Jun 2023.
Haute Autorité de Santé. Stratégie de vaccination pour la prévention des infections invasives à méningocoques : Le sérogroupe B et la place de BEXSERO®. Available at: https://www.has-sante.fr/jcms/p_3066921/fr/strategie-de-vaccination-pour-la-prevention-des-infections-invasives-a-meningocoques-le-serogroupe-b-et-la-place-de-bexsero#:~:text=Depuis%202013%2C%20l'utilisation%20de,%2C%20%C3%A9pid%C3%A9mie%2C%20hyperend%C3%A9mie%20localis%C3%A9e. Accessed 14 Jun 2023.
Stefanelli P, Fazio C, Vacca P, et al. An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11. Clin Microbiol Infect. 2019;25:111.e1–e4.
Article PubMed CAS Google Scholar
Outbreak News Today. Meningococcal disease outbreak in São Paulo, Health officials reinforce importance of vaccination. Available at: http://outbreaknewstoday.com/meningococcal-disease-outbreak-in-sao-paulo-health-officials-reinforce-importance-of-vaccination-61531/. Accessed 2 Mar 2023.
US Centers for Disease Control and Prevention. Meningococcal disease outbreak among gay, bisexual men in Florida, 2021–23. Available at: https://www.cdc.gov/meningococcal/outbreaks/FL2022.html. Accessed 12 Sep 2023.
Okonji OC, Rackimuthu S, Gangat SA, et al. Meningitis during COVID -19 pandemic in the Democratic Republic of Congo: a call for concern. Clin Epidemiol Glob Health. 2022;13:100955.
Article PubMed PubMed Central CAS Google Scholar
Neal KR, Nguyen-Van-Tam JS, Jeffrey N, et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ. 2000;320:846–9.
Article PubMed PubMed Central CAS Google Scholar
Choi H, Lee HM, Lee W, et al. Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea. PLoS ONE. 2021;16:e0244716.
Article PubMed PubMed Central CAS Google Scholar
McMillan M, Walters L, Mark T, et al. B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia. Hum Vaccin Immunother. 2019;15:987–94.
Article PubMed PubMed Central Google Scholar
Watle SV, Caugant DA, Tunheim G, et al. Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors. Epidemiol Infect. 2020;148:e80.
Article PubMed PubMed Central CAS Google Scholar
Cohen R, Pettoello-Mantovani M, Somekh E, Levy C. European pediatric societies call for an implementation of regular vaccination programs to contrast the immunity debt associated to coronavirus disease–2019 pandemic in children. J Pediatr. 2022;242:260–1.e3.
Article PubMed CAS Google Scholar
Billard MN, Bont LJ. Quantifying the RSV immunity debt following COVID-19: a public health matter. Lancet Infect Dis. 2023;23:3–5.
Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration—United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:591–3.
Comments (0)